RTW INVESTMENTS, LP - CYTOMX THERAPEUTICS INC ownership

CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 120 filers reported holding CYTOMX THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.69 and the average weighting 0.0%.

Quarter-by-quarter ownership
RTW INVESTMENTS, LP ownership history of CYTOMX THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$5,215,000
-66.2%
2,849,707
-50.7%
0.14%
-57.7%
Q1 2022$15,432,000
-40.9%
5,779,700
-4.1%
0.32%
-16.3%
Q4 2021$26,109,000
+266.1%
6,029,700
+330.4%
0.38%
+252.8%
Q3 2021$7,131,000
-19.6%
1,400,9390.0%0.11%
-19.4%
Q2 2021$8,868,000
-25.2%
1,400,939
-8.7%
0.13%
-27.6%
Q1 2021$11,856,000
+18.5%
1,533,758
+0.4%
0.18%
+10.1%
Q4 2020$10,004,000
-1.4%
1,527,352
+0.1%
0.17%
-31.1%
Q3 2020$10,148,000
-19.6%
1,526,003
+0.8%
0.24%
-31.3%
Q2 2020$12,616,000
+54.2%
1,514,476
+42.0%
0.36%
+0.9%
Q1 2020$8,182,000
-5.3%
1,066,791
+2.6%
0.35%
+8.0%
Q4 2019$8,639,000
+18.2%
1,039,593
+5.0%
0.33%
-25.1%
Q3 2019$7,310,000
-34.1%
990,463
+0.2%
0.44%
-26.5%
Q2 2019$11,089,000
+6.9%
988,319
+2.4%
0.59%
-16.4%
Q1 2019$10,376,000
-24.4%
965,252
+6.2%
0.71%
-44.6%
Q4 2018$13,720,000908,5861.28%
Other shareholders
CYTOMX THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 524,763$7,924,0003.84%
Congress Park Capital LLC 123,311$1,862,0002.05%
Perceptive Advisors 2,911,715$43,588,0001.66%
RTW INVESTMENTS, LP 908,586$13,720,0001.28%
HAMILTON LANE ADVISORS LLC 68,753$1,038,0000.91%
HARBOURVEST PARTNERS LLC 79,193$1,196,0000.57%
SPHERA FUNDS MANAGEMENT LTD. 273,151$4,125,0000.46%
Exane Asset Management 50,000$755,000,0000.44%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 622,548$9,400,0000.38%
Cormorant Asset Management, LP 296,712$4,480,0000.36%
View complete list of CYTOMX THERAPEUTICS INC shareholders